{
  "trial_id": "NCT01503671",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "peritoneal dialysis at the investigators hospital for more than 6 months with higher pro-inflammation serum cytokine levels (C-reactive protein > 0.2mg/dL)",
      "label": "met"
    },
    {
      "criterion": "Atorvastatin (40mg/day) would be given to those who were allocated to the intervention group",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "disease, cardiomyopathy, pericardial disease and renal insufficiency",
      "label": "triggers"
    },
    {
      "criterion": "History of hypersensitivity to any of the study drugs",
      "label": "unknown"
    }
  ],
  "notes": "Patient has a history of CAD, recently noted abdominal mass, and presents with fevers/rigors and bandemia. She underwent EUS with biopsy, which showed pancreatic adenocarcinoma at the head of pancreas.",
  "_meta": {
    "topic_id": "15",
    "trial_id": "NCT01503671",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}